Author + information
- Received January 19, 1994
- Revision received May 5, 1994
- Accepted May 10, 1994
- Published online October 1, 1994.
- Mauro Giacca, MD, PhD∗,a,
- Giovanni Maria Severini, MSc1,a,
- Luisa Mestroni, MD2,a,
- Alessandro Salvi, MDa,∗,
- Gerardina Lardieri, MDa,∗,
- Arturo Falaschi, MD, PhDa and
- Fulvio Camerini, MDa,∗
- ↵∗Address for correspondence: Dr. Mauro Giacca, International Centre for Genetic Engineering and Biology, Padriciano, 99, 34012 Trieste, Italy.
Objectives. The purpose of this study was to determine the prevalence of enteroviral infection in the myocardium of patients with idiopathic dilated cardiomyopathy by using a highly sensitive and specific detection technique.
Background. Recent molecular studies have suggested that enteroviral persistence (in particular, coxsackieviruses type B) may underlie idiopathic myocarditis and dilated cardiomyopathy.
Methods. The method used to detect enterovirus-specific ribonucleic acids (RNAs) is based on reverse transcription and nested polymerase chain reaction amplification with four pairs of primers from the conserved 5′ noncoding region of the enteroviral genome. Several members of the Enterovirusgenus are detectable by this assay (coxsackieviruses B1 to B6; polioviruses 1 to 3; echoviruses 9, 19 and 31), with a sensitivity threshold close to the detection of a single molecule of viral RNA in 1 mg of tissue sample. Endomyocardial tissue samples from 84 subjects were analyzed (77 samples obtained from left endomyocardial biopsies, 7 from expianted hearts). The subjects comprised 63 study patients (53 with dilated cardiomyopathy, 3 with idiopathic myocarditis, 1 with right ventricular dysplasia, 1 with restrictive cardiomyopathy, 1 with eosinophilic myocarditis, 1 with primary ventricular fibrillation and 3 with myocarditis of known etiology) and 21 control subjects with other diseases.
Results. Positive signals were obtained only in samples from six study patients (four with dilated cardiomyopathy, one with right ventricular dysplasia and one with myocarditis). Samples from control subjects, uninfected rat myocardium and cultured cell lines yielded systematically negative results. Moreover, the nucleotide sequence analysis of the amplification products from patients with positive samples raised doubts about the true positivity of these samples.
Conclusions. This study suggests that the persistence of enteroviral RNA in dilated cardiomyopathy is not a major cause of the disease and that a careful analysis of polymerase chain reaction amplification products is essential in any study in which this technique is pushed to high sensitivity thresholds.
- Received January 19, 1994.
- Revision received May 5, 1994.
- Accepted May 10, 1994.